# Transit Time and Bacterial Overgrowth Using SmartPill Capsule

> **NCT00577772** · NA · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 17 (actual)

## Conditions studied

- Small Bowel Bacterial Overgrowth
- Gastrointestinal Diseases
- Stomach Diseases
- Digestive System Diseases

## Interventions

- **DRUG:** Xifaxan
- **DEVICE:** SmartPill
- **PROCEDURE:** Lactulose hydrogen breath test (H_2BT)

## Key facts

- **NCT ID:** NCT00577772
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-11
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** Enrollment Goal Not Met
- **Last updated:** 2012-10-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00577772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00577772, "Transit Time and Bacterial Overgrowth Using SmartPill Capsule". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00577772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*